Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A mutation in the FAM83G gene is linked to skin and hair abnormalities in two related individuals.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

PRP injections may improve hair loss condition, but more research needed.

Minoxidil and finasteride are promising drugs that can prevent hair loss and promote new growth in people with common hair loss condition.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Scalp biopsies are important for diagnosing hair loss conditions.

A woman's complete hair loss condition improved after recovering from COVID-19.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Some people with alopecia areata, a hair loss condition, get better within a year without treatment, but it can happen again.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Acne keloidalis nuchae is a hair loss condition affecting men of African descent, causing scar-like bumps on the scalp and neck.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Different treatments are effective for hair loss conditions, but results vary by individual factors.